Inherited interstitial lung disease
MONDO:0031199An instance of interstitial lung disease that is caused by an inherited modification of the individual's genome.
70 clinical trials for this condition and its sub-types, 5 tagged with Inherited interstitial lung disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Inherited interstitial lung disease
-
Interstitial lung disease 2 2 trials
-
Niemann-Pick disease type B 1 trial
-
9 sub-types
- Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7 0 trials
- Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8 0 trials
- Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 9 0 trials
- Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1 0 trials
- Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2 0 trials
- Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 0 trials
- Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4 0 trials
- Pulmonary fibrosis and/or bone marrow failure, telomere-related, 5 0 trials
- Pulmonary fibrosis and/or bone marrow failure, telomere-related, 6 0 trials
-
Hermansky-Pudlak syndrome with pulmonary fibrosis 0 trials · 1 incl. sub-types
2 sub-types
- Hermansky-Pudlak syndrome 1 1 trial
- Hermansky-Pudlak syndrome 4 1 trial
-
Rajab interstitial lung disease with brain calcifications 0 trials · 1 incl. sub-types
2 sub-types
-
Familial hypocalciuric hypercalcemia 0 trials · 1 incl. sub-types
3 sub-types
-
Lane Hamilton syndrome 0 trials
-
Interstitial lung disease 1 0 trials
-
Could a simple sugar pill fix faulty telomeres? early trial launches
Disease control Recruiting nowThis early-stage trial is testing whether a combination of two natural substances, deoxycytidine and deoxythymidine, is safe for people with telomere biology disorders. These rare genetic conditions cause premature aging, bone marrow failure, and lung scarring. Up to 36 participa…
Phase 1 • Sponsor: Suneet Agarwal • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Hope for High-Risk families: drug aims to stop lung scarring before it starts
Prevention Recruiting nowThis study tests a drug called nerandomilast in 80 people aged 40+ who have early lung changes and a family history of pulmonary fibrosis. Participants take either the drug or a placebo twice daily for up to 3 years. Doctors monitor lung function and scans to see if the drug slow…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
Family lung disease study aims to uncover hidden risks
Knowledge-focused Recruiting nowThis study follows 750 healthy family members of people with familial pulmonary fibrosis, a lung scarring disease that runs in families. Researchers will track participants with yearly questionnaires and in-person visits every two years to see who develops the disease and why. Th…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Scientists hunt for genetic clues in familial lung disease
Knowledge-focused Recruiting nowThis study aims to uncover the genetic causes of familial pulmonary fibrosis, a progressive lung disease that runs in families. Researchers will analyze DNA from 126 adults with a family history of the condition, looking for gene changes linked to lung scarring. The goal is to im…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC